Skip to main content
Log in

The effect of FR167653 on cerebral ischemia-reperfusion injury after retrograde cerebral perfusion in a canine model

  • Original Articles
  • Published:
International Journal of Angiology

Abstract

Retrograde cerebral perfusion (RCP) has recently been reported to be useful for the repair of aortic arch aneurysms. However, there is a possibility that RCP supplies a limited amount of blood to the brain [1] and ischemia-reperfusion injury may occur after RCP. FR167653 (FR) is characterized as a potent suppressant of interleukin-1β and tumor necrosis factor-α. We investigated the role of FR in preventing cerebral ischemia-reperfusion injury after RCP in a canine model. A total of 12 mongrel dogs was divided into two groups: in the FR group (n=6), FR167653 (1 mg/kg/hour) was continuously administered during the period of RCP and rewarming; in the control group (n=6), a physiological saline solution was administered at the same dosage as the FR167653 during the same period. Following hypothermia (20°C) using cardiopulmonary bypass and circulatory arrest, RCP was performed by infusing oxygenated blood via the bilateral internal maxillary veins for 60 minutes at a perfusion pressure of 25 mmHg. The cerebral blood flow (CBF), cerebral metabolic rate for glucose (CMRGlu) and oxygen (CMRO2), and excretion of carbon dioxide (ExCO2) were measured. These results were expressed as the percentage of change from baseline values established immediately after anesthesia. CBF was significantly (p<0.05) higher in the FR group than in the control group at 40 (159±25% and 82±21%, respectively) and 60 minutes (177±30% and 83±14%, respectively) after RCP. The lactate/pyruvate ratio of blood returned from the brain tissues was significantly (p<0.05) lower in the FR group than in the control group at 40 and 60 minutes after RCP. CMRGlu was significantly (p<0.05) higher in the FR group than in the control group 60 minutes after RCP. There was no significant difference in CMRO2 and ExCO2 between the two groups. It is concluded that FR167653 appears to be effective in protecting the brain from ischemia-reperfusion injury after RCP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ye J, Yang L, Del Bigio MR, Summers R, Jackson D, Somorjai RL, Salerno TA, Deslauriers R (1997) Retrograde cerebral perfusion provides limited distribution of blood to the brain: A study in pigs. J Thorac Cardiovasc Surg 114:660–665.

    Google Scholar 

  2. Kamoshita N, Takeyoshi I, Ohwada S, Iino Y, Morishita Y (1997) The effect of FR167653 on pulmonary ischemia-reperfusion injury in dogs. J Heart Lung Transplant 16:1062–1072.

    Google Scholar 

  3. Yamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara M (1996) Effect of FR167653, a cytokine suppressive agent, on endotoxininduced disseminated intravascular coagulation. Eur J Pharmacol 314:137–142.

    Google Scholar 

  4. Sato Y, Hasegawa Y, Takahashi T, Ishikawa S, Morishita Y (1997) Optimal brain temperature for retrograde cerebral perfusion in dogs. Int J Angiol 7:632–637.

    Google Scholar 

  5. Usui A, Oohara K, Liu T, Murase M, Tanaka M, Takeuchi E, Abe T (1994) Determination of optimum retrograde cerebral perfusion conditions. J Thorac Cardiovasc Surg 107:300–308.

    Google Scholar 

  6. Usui A, Hotta T, Hiroura M, Murase M, Maeda M, Koyama T, Tanaka M, Takeuchi E, Yasuura K, Watanabe T, Abe T (1992) Retrograde cerebral perfusion through a superior vena caval cannula protects the brain. Ann Thorac Surg 53:47–53.

    Google Scholar 

  7. Miller MM (1964) The venous system. In: Anatomy of the Dog, Miller MM (ed). WB Saunders: Philadelphia, pp 389–435.

    Google Scholar 

  8. Ueda Y, Miki S, Okita Y, Tahata T, Ogino H, Sakai T, Morioka K, Matsuyama K (1994) Protective effect of continuous retrograde cerebral perfusion on the brain during deep hypothermic systemic circulatory arrest. J Cardiovasc Surg (Torino) 9:584–595.

    Google Scholar 

  9. Seekamp A, Warren JS, Remick DG, Till GO, Ward PA (1993) Requirements for tumor necrosis factor-α and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol 143:453–463.

    Google Scholar 

  10. Serrick C, Adoumie R, Giaid A, Shennib H (1994) The early release of interleukin-2, tumor necrosis factor-α and interleukin-γ after ischemia reperfusion injury in the lung allograft. Transplantation 58:1158–1162.

    Google Scholar 

  11. Palace GP, Del Vecchio PJ, Horgan MJ, Malik AB (1993) Release of tumor necrosis factor after pulmonary artery occlusion and reperfusion. Am Rev Respir Dis 147:143–147.

    Google Scholar 

  12. Larrick JW, Graham D, Toy K, Lin LS, Senyk G, Fendly BM (1987) Recombinant tumor necrosis factor causes activation of human granulocytes. Blood 69:640–644.

    Google Scholar 

  13. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA Jr (1985) Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors. J Immunol 135:2069–2073.

    Google Scholar 

  14. Shalaby MR, Palladino MA Jr, Hirabayashi SE, Essalu TE, Shepard HM, Aggarwal BB (1987) Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leuk Biol 41:196–204.

    Google Scholar 

  15. Zamora CA, Baron DA, Heffner JE (1993) Thromboxane contributes to pulmonary hypertention in ischemia-reperfusion lung injury. J Appl Physiol 74:224–229.

    Google Scholar 

  16. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA (1988) Interleukin 1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 81:1162–1172.

    Google Scholar 

  17. Canadian Cooperative Study Group (1978) Randomized trial of aspirin and sulfin pyrazone in threatened stroke. N Engl J Med 299:53–59.

    Google Scholar 

  18. Fisher M, Zipser R (1985) Increased excretion of immunoreactive thromboxane B2 in cerebral ischemia. Stroke 16:10–14.

    Google Scholar 

  19. Koudstaal PJ, Ciabattoni G, van Gijin J, Nieuwenhuis HK, de Groot PG, Sixma JJ, Patrono C (1993) Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke 24:219–223.

    Google Scholar 

  20. Johnson J, Brigham KL, Jesmok G, Meyrick B (1991) Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor-α. Am Rev Respir Dis 144:179–186.

    Google Scholar 

  21. McCord JM (1985) Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159–163.

    Google Scholar 

  22. Shapiro HM (1985) Post-cardiac arrest therapy: Calcium entry blockade and brain resuscitation. Anesthesiology 62:384–387.

    Google Scholar 

  23. Steen PA, Newberg LA, Milde JH, Michenfelder JD (1984) Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 4:82–87.

    Google Scholar 

  24. Yoshimura N, Okada M, Ota T, Nohara H (1995) Pharmacologic intervention for ischemic brain edema after retrograde cerebral perfusion. J Thorac Cardiovasc Surg 109:1173–1181.

    Google Scholar 

  25. Nojima T, Magara T, Nakajima Y, Waterida S, Onoe M, Sugita T, Mori A (1994) Optimal perfusion pressure for experimental retrograde cerebral perfusion. J Cardiovasc Surg (Torino) 9:548–559.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Oshima, K., Sato, Y., Takeyoshi, I. et al. The effect of FR167653 on cerebral ischemia-reperfusion injury after retrograde cerebral perfusion in a canine model. International Journal of Angiology 8, 143–146 (1999). https://doi.org/10.1007/BF01616441

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01616441

Keywords

Navigation